Vbi Vaccines Stock Piotroski F Score

VBIVQ Stock   0.0005  0.0001  16.67%   
This module uses fundamental data of VBI Vaccines to approximate its Piotroski F score. VBI Vaccines F Score is determined by combining nine binary scores representing 3 distinct fundamental categories of VBI Vaccines. These three categories are profitability, efficiency, and funding. Some research analysts and sophisticated value traders use Piotroski F Score to find opportunities outside of the conventional market and financial statement analysis.They believe that some of the new information about VBI Vaccines financial position does not get reflected in the current market share price suggesting a possibility of arbitrage. Check out VBI Vaccines Altman Z Score, VBI Vaccines Correlation, VBI Vaccines Valuation, as well as analyze VBI Vaccines Alpha and Beta and VBI Vaccines Hype Analysis.
To learn how to invest in VBI Stock, please use our How to Invest in VBI Vaccines guide.
  
As of 12/26/2024, Short and Long Term Debt is likely to drop to about 36.1 M. In addition to that, Long Term Debt is likely to drop to about 34.3 M.
At this time, it appears that VBI Vaccines' Piotroski F Score is Frail. Although some professional money managers and academia have recently criticized Piotroski F-Score model, we still consider it an effective method of predicting the state of the financial strength of any organization that is not predisposed to accounting gimmicks and manipulations. Using this score on the criteria to originate an efficient long-term portfolio can help investors filter out the purely speculative stocks or equities playing fundamental games by manipulating their earnings..
2.0
Piotroski F Score - Frail
Current Return On Assets

N/A

Focus
Change in Return on Assets

N/A

Focus
Cash Flow Return on Assets

Negative

Focus
Current Quality of Earnings (accrual)

Decreasing

Focus
Asset Turnover Growth

N/A

Focus
Current Ratio Change

N/A

Focus
Long Term Debt Over Assets Change

Lower Leverage

Focus
Change In Outstending Shares

Decrease

Focus
Change in Gross Margin

N/A

Focus

VBI Vaccines Piotroski F Score Drivers

The critical factor to consider when applying the Piotroski F Score to VBI Vaccines is to make sure VBI is not a subject of accounting manipulations and runs a healthy internal audit department. So, if VBI Vaccines' auditors report directly to the board (not management), the managers will be reluctant to manipulate simply due to the fear of punishment. On the other hand, the auditors will be free to investigate the ledgers properly because they know that the board has their back. Below are the main accounts that are used in the Piotroski F Score model. By analyzing the historical trends of the mains drivers, investors can determine if VBI Vaccines' financial numbers are properly reported.
Current ValueLast YearChange From Last Year 10 Year Trend
Net Debt21.7 M24.4 M
Fairly Down
Slightly volatile
Total Current Liabilities44.7 M75.7 M
Way Down
Slightly volatile
Non Current Liabilities Total3.5 M3.7 M
Notably Down
Very volatile
Total Assets132.3 M87 M
Way Up
Slightly volatile
Total Current Assets34.4 M36.2 M
Notably Down
Slightly volatile

VBI Vaccines F Score Driver Matrix

One of the toughest challenges investors face today is learning how to quickly synthesize historical financial statements and information provided by the company, SEC reporting, and various external parties in order to project the various growth rates. Understanding the correlation between VBI Vaccines' different financial indicators related to revenue, expenses, operating profit, and net earnings helps investors identify and prioritize their investing strategies towards VBI Vaccines in a much-optimized way.

About VBI Vaccines Piotroski F Score

F-Score is one of many stock grading techniques developed by Joseph Piotroski, a professor of accounting at the Stanford University Graduate School of Business. It was published in 2002 under the paper titled Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers. Piotroski F Score is based on binary analysis strategy in which stocks are given one point for passing 9 very simple fundamental tests, and zero point otherwise. According to Mr. Piotroski's analysis, his F-Score binary model can help to predict the performance of low price-to-book stocks.

Short Long Term Debt

36.09 Million

At this time, VBI Vaccines' Short and Long Term Debt is relatively stable compared to the past year.

About VBI Vaccines Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze VBI Vaccines's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of VBI Vaccines using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of VBI Vaccines based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Pair Trading with VBI Vaccines

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if VBI Vaccines position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in VBI Vaccines will appreciate offsetting losses from the drop in the long position's value.

Moving together with VBI Stock

  0.62EMMA Emmaus Life SciencesPairCorr

Moving against VBI Stock

  0.53EPRX Eupraxia PharmaceuticalsPairCorr
  0.48GRCE Grace Therapeutics, Symbol ChangePairCorr
  0.44FBIOP Fortress Biotech PrefPairCorr
  0.39FRTX Fresh Tracks TherapeuticsPairCorr
  0.37UPB Upstream Bio,PairCorr
The ability to find closely correlated positions to VBI Vaccines could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace VBI Vaccines when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back VBI Vaccines - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling VBI Vaccines to buy it.
The correlation of VBI Vaccines is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as VBI Vaccines moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if VBI Vaccines moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for VBI Vaccines can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Additional Tools for VBI Stock Analysis

When running VBI Vaccines' price analysis, check to measure VBI Vaccines' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy VBI Vaccines is operating at the current time. Most of VBI Vaccines' value examination focuses on studying past and present price action to predict the probability of VBI Vaccines' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move VBI Vaccines' price. Additionally, you may evaluate how the addition of VBI Vaccines to your portfolios can decrease your overall portfolio volatility.